76
|
Kaul K, Koliaki C, Nowotny B, Rütter R, Menart B, Blumensatt M, Ouwens M, Roden M. O-glycosyltransferase activation in leukocytes contributes to early renal function impairment in type 2 diabetes. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
77
|
Wartha J, Simon MC, Strom A, Fingberg W, Weiss J, Roden M, Burkart V. Beschleunigte Diabetesentwicklung in Toll-like Rezeptor 4-defizienten Non-obese Diabetic Mäusen ist assoziiert mit gestörtem Fettstoffwechsel und veränderter Darmmorphologie. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
78
|
Markova M, Hornemann S, Sucher S, Herder C, Roden M, Prokisch H, Pivovarova O, Pfeiffer A. A high-protein diet reduces liver fat content and improves glomerular filtration rate in subjects with type 2 diabetes. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
79
|
Burkart V, Nowotny B, Zivehe F, Simon MC, Straßburger K, Finner H, Herder C, Szendrödi J, Roden M. Negative Assoziation von Insulinantikörper-Spiegeln und Insulinsensitivität in Autoantikörper-positiven Erwachsenen mit neu diagnostiziertem Diabetes. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
80
|
Schamarek I, Herder C, Nowotny B, Straßburger K, Carstensen-Kirberg M, Nowotny P, Strom A, Püttgen S, Müssig K, Szendroedi J, Ziegler D, Roden M. Association between interleukin-6 and motor nerve conduction in individuals with newly diagnosed diabetes: results from the German Diabetes Study. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
81
|
Pivovarova O, Markova M, Hornemann S, Sucher S, Kemper M, Prokisch H, Roden M, Herder C, Pfeiffer AFH. Effects of an isocaloric high-protein diet on inflammatory status in type 2 diabetes. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
82
|
Carstensen-Kirberg M, Ruige J, Barbosa D, Partke U, Lehr S, Roden M, Herder C, Ouwens DM. Assoziation zwischen dem anti-inflammatorischen Adipokin Sfrp5 und chemotaktischen Proteinen im Menschen. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
83
|
Gancheva S, Bierwagen A, Begovatz P, Lundbom J, Nowotny P, Giani G, Hoffmann B, Szendroedi J, Roden M. Newly diagnosed type 1 diabetes patients exhibit lower hepatic ATP concentrations despite normal hepatocellular lipid accumulation. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
84
|
Klüppelholz B, Thorand B, Koenig W, de las Heras Gala T, Meisinger C, Huth C, Giani G, Franks PW, Roden M, Rathmann W, Peters A, Herder C. Assoziationen zwischen Biomarkern der subklinischen Entzündung und HbA1c-Veränderungen vor der Diagnose des Typ-2-Diabetes: Ergebnisse aus der KORA S4/F4-Kohorte. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
85
|
Ratjen I, Weber KS, Roden M, Herrmann ME, Müssig K. Type 1 diabetes mellitus and exercise in competitive athletes. Exp Clin Endocrinol Diabetes 2015; 123:419-22. [PMID: 25853705 DOI: 10.1055/s-0035-1545344] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
AIMS The number of patients with type 1 diabetes mellitus who are actively participating in competitive sports is increasing. Here, we aimed to assess individual experiences of competitive athletes with type 1 diabetes and to compare these experiences with current recommendations. METHODS A survey of 20 competitive athletes with type 1 diabetes, categorized as endurance (n=10) and non-endurance (n=10) athletes, was performed. RESULTS Endurance and non-endurance athletes did not differ in gender distribution, age, body mass index, and known diabetes duration. Self-reported target blood glucose values prior to exercise were lower in non-endurance than in endurance athletes (195±34 vs. 137±28 mg/dl, P=0.001). The majority of all athletes experienced activity-induced hypo- and hyperglycemic events, independently of exercise type. However, endurance athletes used additional carbohydrate units to prevent activity-induced hypoglycemic events more frequently without monitoring their blood glucose levels than non-endurance athletes (50% vs. 0%, P=0.01). The reduction of the insulin dose on training and competition days compared to days without exercise was similar for endurance and non-endurance athletes. CONCLUSION These results point to a very individual adaption of the athlete's therapy during training and competition. However, there are distinct differences in diabetes management between endurance and non-endurance athletes.
Collapse
|
86
|
Weber K, Nowotny B, Strassburger K, Simon MC, Pacini G, Szendroedi J, Müssig K, Herder C, Roden M. Association of subclinical inflammation with early changes of glycemic control in patients with recent-onset type 1 or type 2 diabetes. Exp Clin Endocrinol Diabetes 2015. [DOI: 10.1055/s-0035-1547773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
87
|
Bönner F, Merx M, Klingel K, Begovatz P, Flögel U, Sager M, Temme S, Jacoby C, Salehi Ravesh M, Grapentin C, Schubert R, Bunke J, Roden M, Kelm M, Schrader J. Monocyte imaging after myocardial infarction with 19F MRI at 3 T: a pilot study in explanted porcine hearts. ACTA ACUST UNITED AC 2015; 16:612-20. [DOI: 10.1093/ehjci/jev008] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2014] [Accepted: 01/12/2015] [Indexed: 12/23/2022]
|
88
|
Bongaerts BWC, Ziegler D, Shaw JE, Heier M, Kowall B, Herder C, Roden M, Peters A, Meisinger C, Rathmann W. A clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies. J Diabetes Complications 2015; 29:44-9. [PMID: 25457462 DOI: 10.1016/j.jdiacomp.2014.09.014] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/28/2014] [Revised: 09/29/2014] [Accepted: 09/30/2014] [Indexed: 11/21/2022]
Abstract
AIMS Since screening for distal sensorimotor polyneuropathy (DSPN) in individuals with diabetes is being underused, our aim was to develop a clinical screening score for identifying individuals with DSPN. METHODS All participants with type 2 diabetes and aged 61-82 years from the German population-based KORA F4 Study (n=177) and the Australian population-based AusDiab Study (n=244) were combined into one study sample. Risk indicators of DSPN were identified and entered into a stepwise model-selection procedure, constructing two consecutive scores with increasing complexity (a base and clinical model). RESULTS The prevalence of DSPN was 18.2% (95% confidence interval (CI): 14.7-22.3). The base model comprised age (years), height (cm), weight (kg), pain or discomfort in the feet and/or legs (yes/no), and duration of diabetes (years), yielding an area under the receiver operating characteristics curve (AUC) of 0.80 (95% CI: 0.76-0.85). The clinical model additionally included diastolic blood pressure (mmHg) and serum creatinine levels (mmol/l). The AUC increased only marginally to 0.82 (0.77-0.87) (p for AUC comparison=0.188). The internal validation of the scores produced similar AUCs. CONCLUSIONS The screening scores developed in this study are a simple tool to differentiate between a high and low likelihood of having DSPN among individuals with type 2 diabetes.
Collapse
|
89
|
Samocha-Bonet D, Dixit VD, Kahn CR, Leibel RL, Lin X, Nieuwdorp M, Pietiläinen KH, Rabasa-Lhoret R, Roden M, Scherer PE, Klein S, Ravussin E. Metabolically healthy and unhealthy obese--the 2013 Stock Conference report. Obes Rev 2014; 15:697-708. [PMID: 25059108 PMCID: PMC4519075 DOI: 10.1111/obr.12199] [Citation(s) in RCA: 129] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2014] [Revised: 05/16/2014] [Accepted: 05/18/2014] [Indexed: 12/12/2022]
Abstract
Obesity is closely associated with cardiovascular diseases and type 2 diabetes, but some obese individuals, despite having excessive body fat, exhibit metabolic health that is comparable with that of lean individuals. The 'healthy obese' phenotype was described in the 1980s, but major advancements in its characterization were only made in the past five years. During this time, several new mechanisms that may be involved in health preservation in obesity were proposed through the use of transgenic animal models, use of sophisticated imaging techniques and in vivo measurements of insulin sensitivity. However, the main obstacle in advancing our understanding of the metabolically healthy obese phenotype and its related long-term health risks is the lack of a standardized definition. Here, we summarize the proceedings of the 13th Stock Conference of the International Association of the Study of Obesity. We describe the current research and highlight the unanswered questions and gaps in the field. Better understanding of metabolic health in obesity will assist in therapeutic decision-making and help identify therapeutic targets to improve metabolic health in obesity.
Collapse
|
90
|
Herder C, Bongaerts BWC, Rathmann W, Heier M, Kowall B, Koenig W, Thorand B, Roden M, Meisinger C, Ziegler D. Association between subclinical inflammation and painful polyneuropathy in an older population: KORA F4 study. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1375016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
91
|
Schloot N, Menart B, Rütter R, Nowotny B, Rosenbauer J, Koliaki C, Kahl S, Simon MC, Szendroedi J, Roden M. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes. Results from the German Diabetes Study (GDS). DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
92
|
Begovatz P, Koliaki C, Strassburger K, Nowotny B, Nowotny P, Giani G, Pacini G, Bunke J, Szendroedi J, Roden M. Pancreatic lipids and insulin secretion in humans with or without type 2 diabetes. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
93
|
Kaul K, Jelenik T, Rokitta I, Kotzka J, Roden M. Changes in renal function in pre-diabetic mice overexpressing SREBP-1c. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1375014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
94
|
Teichert T, Hellwig A, Peßler A, Hellwig M, Vossoughi M, Sugiri D, Vierkötter A, Schulte T, Roden M, Hoffmann B, Schikowski T, Luckhaus C, Krämer U, Henle T, Herder C. Advanced Glycation Endproducts im Plasma von Frauen ohne und mit gestörter Nüchternglukose: Ergebnisse aus der SALIA-Studie. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
95
|
Gancheva S, Koliaki C, Bierwagen A, Nowotny P, Nagel A, Achterath N, Tinnes K, Eßer M, Fritsche A, Heni M, Häring HU, Szendrödi J, Roden M. Intranasal insulin does not alter endogenous glucose production, but decreases liver fat and increases hepatic γATP in humans. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
96
|
Müller-Lühlhoff S, Jelenik T, Hartwig S, Lehr S, Nowotny P, Roden M, Al-Hasani H, Castañeda TR. Long-term effects of chronic variable stress on insulin sensitivity. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
97
|
Strom A, Brüggemann J, Ziegler I, Ringel B, Roden M, Ziegler D. Dermale Überexpression der mitochondrialen Superoxid-Dismutase bei kürzlich diagnostiziertem Typ 2 Diabetes. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1375015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
98
|
Reinbeck AL, Ingenwerth M, Stahr A, Partke HJ, Gall CV, Burkart V, Roden M. Gestörte hypothalamische Expression des Haupt-Uhrengens Per1 zum Zeitpunkt der Diabetesmanifestation im Tiermodell des Typ 1 Diabetes. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
99
|
Carstensen M, Koliaki C, Nowotny P, Röhrig K, Jankowiak F, Krausch M, Knoefel WT, Schlensak M, Szendrödi J, Herder C, Roden M. Assoziation von Sfrp5- und Wnt5a-Expression in der Leber mit Entzündungsreaktionen und Hyperlipidämie im Menschen. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1375079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
100
|
Jelenik T, Bottermann K, Möllendorf S, Gödecke A, Kotzka J, Kelm M, Roden M, Szendroedi J. Mice with insulin resistance and non-alcoholic fatty liver are characterized by cardiac hypertrophy and increased oxidative stress. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1375107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|